Biotech firm Valar Labs takes in $22m Series A

DCVC and Andreessen Horowitz led the round with participation from Pear VC.

31 May 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.